Bill Burns joins Shire's board
This article was originally published in Scrip
Shire has elected Bill Burns to its board as a non executive director and has also appointed him a member of the company's remuneration committee. Mr Burns has a distinguished career in the global pharmaceutical industry, having worked for Roche for many years; most recently as CEO of their pharmaceuticals division and as a member of the Roche Group corporate executive committee.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.